Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The role of engineered materials in mucosal vaccination strategies
Solovyev et al., 2018
Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over
doi: 10.1136/bmjopen-2023-072707 21 ProbstLMonneratSVogtDRLengsfeldSBurkardTMeienbergAet al
van Calker D, Biber K, Domschke K, Serchov T
While previous research primarily focused on T2D or obesity-specific populations, our study specifically examines therapeutic implications for MASLD patients, addressing a critical knowledge gap regarding the benefits of combination therapy on various clinical endpoints including all-cause hospitalization, all-cause mortality, MAKE, and MALO in this population
US$ 29.46
US$ 24.01
US$ 27.08
US$ 29.39
US$ 27.22
US$ 24.62
